+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Murine CD4⁺CD25⁻ cells activated in vitro with PMA/ionomycin and anti-CD3 acquire regulatory function and ameliorate experimental colitis in vivo



Murine CD4⁺CD25⁻ cells activated in vitro with PMA/ionomycin and anti-CD3 acquire regulatory function and ameliorate experimental colitis in vivo



Bmc Gastroenterology 12: 172-172



Induced regulatory T (iTreg) lymphocytes show promise for application in the treatment of allergic, autoimmune and inflammatory disorders. iTreg cells demonstrate advantages over natural Treg (nTreg) cells in terms of increased number of starting population and greater potential to proliferate. Different activation methods to generate iTreg cells result in iTreg cells that are heterogeneous in phenotype and mechanisms of suppression. Therefore it is of interest to explore new techniques to generate iTreg cells and to determine their physiological relevance.Using phorbol myristate acetate (PMA)/ionomycin and anti-CD3 activation of CD4+CD25- cells we generated in vitro functional CD4+CD25+ iTreg (TregPMA) cells. Functionality of the generated TregPMA cells was tested in vivo in a mouse model of inflammatory bowel disease (IBD) - CD45RB transfer colitis model.TregPMA cells expressed regulatory markers and proved to ameliorate the disease phenotype in murine CD45RB transfer colitis model. The body weight loss and disease activity scores for TregPMA treated mice were reduced when compared to diseased control group. Histological assessment of colon sections confirmed amelioration of the disease phenotype. Additionally, cytokine analysis showed decreased levels of proinflammatory colonic and plasma IL-6, colonic IL-1 ? and higher levels of colonic IL-17 when compared to diseased control group.This study identifies a new method to generate in vitro iTreg cells (TregPMA cells) which physiological efficacy has been demonstrated in vivo.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 036650875

Download citation: RISBibTeXText

PMID: 23198878

DOI: 10.1186/1471-230x-12-172


Related references

CD4+CD25+ T regulatory cells induced by LPS-activated bone marrow dendritic cells suppress experimental autoimmune uveoretinitis in vivo. Graefe's Archive for Clinical and Experimental Ophthalmology 245(2): 221-229, 2007

IL-10 and TGF-beta induce alloreactive CD4+CD25- T cells to acquire regulatory cell function. Blood 101(12): 5076-5083, 2003

IL-2/anti-IL-2 complexes ameliorate lupus nephritis by expansion of CD4 + CD25 + Foxp3 + regulatory T cells. Kidney International 91(3): 603-615, 2017

Role of CD4+ CD25+ regulatory T cells in melatonin-mediated inhibition of murine gastric cancer cell growth in vivo and in vitro. Anatomical Record 294(5): 781-788, 2011

Differences in the Induction of Induced Human CD4+ CD25+ FoxP3+ T-Regulatory Cells and CD3+ CD8+ CD28a T-Suppressor Cells Subset Phenotypes In Vitro Comparison of Phorbol 12-Myristate 13-Acetate/Ionomycin and Phytohemagglutinin Stimulation. 2013

Differences in the induction of induced human CD4(+) CD25(+) FoxP3(+) T-regulatory cells and CD3(+) CD8(+) CD28(-) T-suppressor cells subset phenotypes in vitro: comparison of phorbol 12-myristate 13-acetate/ionomycin and phytohemagglutinin stimulation. Transplantation Proceedings 45(5): 1822-1831, 2013

Cd4+Cd25+ Regulatory T Cells Cure Murine Colitis: The Role of Il-10, Tgf-, and Ctla4. The Journal of Immunology 171(10): 5012-5017, 2003

CD4+CD25+ Regulatory T Cells Cure Murine Colitis: The Role of IL-10, TGF-b, and CTLA4. Journal of Immunology 171(10): 12-17, 2003

CD4+CD25+ regulatory T cells cure murine colitis: the role of IL-10, TGF-beta, and CTLA4. Journal of Immunology 171(10): 5012-5017, 2003

Anti-interleukin 12 regulates apoptosis of activated Th1 T cells in murine experimental granulomatous colitis. Gastroenterology 112(4 Suppl. ): A978, 1997

The in vitro anti-inflammatory effects of recombinant anti-CD25 immunotoxin on lamina propria T cells of patients with inflammatory bowel disease are not sufficient to cure experimental colitis in mice. International Journal of Colorectal Disease 17(2): 77-84, 2002

Probiotics Ameliorate Recurrent Th1-Mediated Murine Colitis by Inducing IL-10 and IL-10-Dependent TGF-b-Bearing Regulatory Cells. Journal of Immunology 174(6): 37-46, 2005

Probiotics Ameliorate Recurrent Th1-Mediated Murine Colitis by Inducing Il-10 and Il-10-Dependent Tgf--Bearing Regulatory Cells. The Journal of Immunology 174(6): 3237-3246, 2005

Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. Journal of Immunology 174(6): 3237-3246, 2005

Blocking inducible co-stimulator in the absence of CD28 impairs Th1 and CD25+ regulatory T cells in murine colitis. International Immunology 16(2): 205-213, 2004